Hypoxia exosome derived CEACAM5 promotes tumor‐associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9
The FASEB Journal · 2024
DOI: 10.1096/fj.202302489rrr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Mujie Ye und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Gastroenterology, Neuroendocrine Tumor Center, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical Un…. Hauptthemen laut MEDLINE: Exosomes, GPI-Linked Proteins, Matrix Metalloproteinase 9, Neuroendocrine Tumors. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Project of supporting the development of universities in Yancheng, China Postdoctoral Science Foundation (China Postdoctoral Foundation Project).
Abstract (Originalsprache)
Exosomes play significant roles in the communications between tumor cells and tumor microenvironment. However, the specific mechanisms by which exosomes modulate tumor development under hypoxia in pancreatic neuroendocrine tumors (pNETs) are not well understood. This study aims to investigate these mechanisms and made several important discoveries. We found that hypoxic exosomes derived from pNETs cells can activate tumor‐associated macrophages (TAM) to the M2 phenotype, in turn, the M2‐polarized TAM, facilitate the migration and invasion of pNETs cells. Further investigation revealed that CEACAM5, a protein highly expressed in hypoxic pNETs cells, is enriched in hypoxic pNETs cell‐derived exosomes. Hypoxic exosomal CEACAM5 was observed to induce M2 polarization of TAM through activation of the MAPK signaling pathway. Coculturing pNETs cells with TAM or treated with hypoxic exosomes enhanced the metastatic capacity of pNETs cells. In conclusion, these findings suggest that pNETs cells generate CEACAM5‐rich exosomes in a hypoxic microenvironment, which in turn polarize TAM promote malignant invasion of pNETs cells. Targeting exosomal CEACAM5 could potentially serve as a diagnostic and therapeutic strategy for pNETs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Gastroenterology, Neuroendocrine Tumor Center, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Institute of Neuroendocrine Tumor, Nanjing Medical Universit…
- Department of Gastroenterology, Yancheng No.1 People's Hospital, Affiliated Hospital of Medical School, Nanjing University, Yancheng, China.
ORCID-Profile: Mujie Ye, Feiyu Lu, Danyang Gu, Bingyan Xue, Lin Xu, Chuanhua Hu, Jinhao Chen, Ping Yu, Hongxia Zheng, Yue Gao, Jianhua Wang, Qiyun Tang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Project of supporting the development of universities in Yancheng
- China Postdoctoral Science Foundation (China Postdoctoral Foundation Project)
- National Natural Science Foundation of China
Zitieren
APA
Ye, M., Lu, F., Gu, D., Xue, B., Xu, L., Hu, C., Chen, J., Yu, P., Zheng, H., Gao, Y., Wang, J., & Tang, Q. (2024). Hypoxia exosome derived CEACAM5 promotes tumor‐associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9. The FASEB Journal. https://doi.org/10.1096/fj.202302489rrr
Vancouver
Ye M, Lu F, Gu D, Xue B, Xu L, Hu C, et al. Hypoxia exosome derived CEACAM5 promotes tumor‐associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9. The FASEB Journal. 2024. doi:10.1096/fj.202302489rrr
BibTeX
@article{Ye2024,
author = {Ye, Mujie and Lu, Feiyu and Gu, Danyang and Xue, Bingyan and Xu, Lin and Hu, Chuanhua and Chen, Jinhao and Yu, Ping and Zheng, Hongxia and Gao, Yue and Wang, Jianhua and Tang, Qiyun},
title = {Hypoxia exosome derived CEACAM5 promotes tumor‐associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202302489rrr}
}
EUVIMED